Genetic Tech (GENE) Rips Higher Early on New State Approval for BREVAGen

Go back to Genetic Tech (GENE) Rips Higher Early on New State Approval for BREVAGen
Genetic Technologies Ltd. (NASDAQ: GENE) Delayed: 0.77 --0 (-0%)
Previous Close $0.77    52 Week High $4.27 
Open $0.77    52 Week Low $1.20 
Day High $0.77    P/E N/A 
Day Low $0.77    EPS $0.00 
Volume 668,315